摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-amino-3-(ethylthio)-2-propenoic acid ethyl ester | 53371-88-3

中文名称
——
中文别名
——
英文名称
3-amino-3-(ethylthio)-2-propenoic acid ethyl ester
英文别名
Ethyl 3-amino-3-(ethylsulfanyl)prop-2-enoate;ethyl 3-amino-3-ethylsulfanylprop-2-enoate
3-amino-3-(ethylthio)-2-propenoic acid ethyl ester化学式
CAS
53371-88-3
化学式
C7H13NO2S
mdl
——
分子量
175.252
InChiKey
ARSQIBBOIIGNAO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    11
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    77.6
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    4-吡啶甲醛3-amino-3-(ethylthio)-2-propenoic acid ethyl ester乙醇 为溶剂, 反应 5.0h, 以2-amino-4-(4-pyridyl)-6-ethylmercapto-4,5-dihydropyridine-3,5-dicarboxylic acid diethyl ester of melting point 156° C is obtained的产率得到6-amino-2-ethylsulfanyl-3,4-dihydro-[4,4']bipyridinyl-3,5-dicarboxylic acid diethyl ester
    参考文献:
    名称:
    2-Amino-4,5-dihydropyridine derivatives and process for their preparation
    摘要:
    6-位被低烷氧基或低烷硫基取代的2-氨基-4,5-二氢吡啶-3,5-二羧酸酯化合物,在4-位可被低烷基、苯基、取代苯基或杂环基取代,具有降压剂和冠状血管扩张剂的作用。这些化合物,其中2-氨基-4-(3-硝基苯基)-6-乙氧基-4,5-二氢吡啶-3,5-二羧酸二乙酯是代表性的实施例,通过醛和在3-位带有烷氧基或烷硫基的3-氨基丙烯酸酯的缩合制备。
    公开号:
    US03985886A1
点击查看最新优质反应信息

文献信息

  • 2-Amino-4,5-dihydropyridine derivatives in pharmaceutical compositions
    申请人:Bayer Aktiengesellschaft
    公开号:US03992545A1
    公开(公告)日:1976-11-16
    2-Amino-4,5-dihydropyridines-3,5-dicarboxylates substituted by lower alkoxy or lower alkylthio in the 6-position and optionally substituted in the 4-position by lower alkyl, phenyl, substituted phenyl or a heterocyclic group are antihypertensive agents and coronary vessel dilators. The compounds, of which 2-amino-4-(3-nitrophenyl)-6-ethoxy-4,5-dihydropyridine-3,5-dicarboxylic acid diethyl ester is a representative embodiment, are prepared through condensation of an aldehyde and a 3-aminoacrylate bearing an alkoxy or alkylthio group in the 3-position.
    在6位被低烷氧基或低烷基代基取代的2-基-4,5-二氢吡啶-3,5-二羧酸酯中,4位可选择性地被低烷基,苯基,取代苯基或杂环基所取代,这些化合物是降压剂和冠状血管扩张剂。这些化合物通过醛和3-丙烯酸酯在3位带有烷氧基或烷基代基的缩合反应制备而成,其中2-基-4-(3-硝基苯基)-6-乙氧基-4,5-二氢吡啶-3,5-二羧酸乙酯是代表性的实施例。
  • Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines
    作者:Karnail S. Atwal、George C. Rovnyak、Joseph Schwartz、Suzanne Moreland、Anders Hedberg、Jack Z. Gougoutas、Mary F. Malley、David M. Floyd
    DOI:10.1021/jm00167a035
    日期:1990.5
    2-Heterosubstituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecar box ylic acid esters 8, which lack the potential CS symmetry of dihydropyridine calcium channel blockers, were prepared and evaluated for biological activity. Biological assays using potassium-depolarized rabbit aorta and radioligand binding techniques showed that some of these compounds are potent mimics of dihydropyridine calcium channel blockers. The combination of a branched ester (e.g. isopropyl, sec-butyl) and an alkylthio group (e.g. SMe) was found to be optimal for biological activity. When compared directly with similarly substituted 2-heteroalkyldihydropyridines 9, dihydropyrimidines 8 were found to be 30-fold less active. The solid-state structure of dihydropyrimidine analogue 8g shows that these compounds can adopt a molecular conformation which is similar to the reported conformation of dihydropyridine calcium channel blockers.
查看更多

同类化合物

甲酰四硫富瓦烯 环己酮,2-[二(甲硫基)亚甲基]- 四硫富瓦烯羧酸铯 噻吩甲酰基三氟丙酮酸钐(III) 5-乙基-2-甲基-噻吩-3-酮 4-羟基-2,5-二甲基噻吩-3(2H)-酮 4-乙基硫烷基-丁-3-烯-2-酮 4,4-二甲基-1,1-双(甲基硫代)-1-戊烯-3-酮 3-[双(甲基磺酰基)亚甲基]-2,4-戊二酮 3,3-双(甲硫基)-2-氰基丙烯酸乙酯 2-氰基-3,3-双(甲基硫代)丙烯酰胺 2-氰-3,3-二(甲硫基)丙烯酸甲酯 2-氯-3-氧代-2,3-二氢-2-噻吩羧酸甲酯 2-氨基-4,5-二氢-3-噻吩甲酰胺 2-乙酰基-3-氨基-3-甲基硫代丙烯腈 2-丙烯酸,3-(十六烷基硫代)-,甲基酯,(Z)- 2-丙烯酸,2-氰基-3-巯基-3-(甲硫基)-,盐乙基酯,钠 2-(环丙基羰基)-3,3-二(甲基硫代)丙烯腈 2-(1,3-二噻戊环-2-亚基)环戊酮 2-(1,3-二噻戊环-2-亚基)环己酮 2,4-戊二酮,3-[氨基(乙硫基)亚甲基]- 2,2-二甲基噻吩-3-酮 1-己烯-3-酮,1,1-二(甲硫基)-2-硝基- 1,3-二硫杂环戊烯-4-羧酸 (3Z)-1,1,1-三氟-4-(甲硫基)-3-丁烯-2-酮 (3E)-4-(甲硫基)-3-戊烯-2-酮 (2Z)-[3-(2-溴乙基)-4-氧代-1,3-噻唑烷-2-亚基]乙酸乙酯 (2Z)-2-(3-乙基-4-氧代-1,3-噻唑烷-2-亚基)乙酸乙酯 (2Z)-(3-甲基-4-氧代-1,3-噻唑烷-2-亚基)乙酸乙酯 (2E)-2-(4-氧代噻唑烷-2-亚基)乙酸丁酯 2-Dimethylcarbamoyl-6-methylsulfanyl-2H-thiopyran-3-carboxylic acid 3-Ethoxy-3-mercapto-2-ethoxycarbonyl-acrylnitril 2-Diethoxycarbonylmethylen-thiazolid-4-on 2-Ethylmercaptocarbonylmethylen-thiazolid-4-on 2,3,4,5-Tetrachlor-5-methylthio-2,4-pentadiensaeurechlorid 3-Hydroxy-3-methylmercapto-2-methoxycarbonyl-acrylnitril 2,ω-Bis-(N-ethylcarboxamido)-1,4-dithiafulven 3,5-Di-(carbamoyl-cyanomethylen)-1,2,4-trithiol [4-Oxo-thiazolidin-(2E)-ylidene]-acetic acid allyl ester (Z)-3-Amino-3-ethylsulfanyl-thioacrylic acid S-ethyl ester 2-Dimethylaminocarbonylmethylen-thiazolidon-(4) 3-((E)-2-Carbamoyl-2-cyano-1-mercapto-vinylsulfanyl)-5-imino-[1,2]dithiolane-4-carboxylic acid amide (E)-2-(cyano-13C)-3-mercapto-3-(methylthio)acrylamide 2-[1-Hydroxy-eth-(E)-ylidene]-dihydro-thiophen-3-one Z-2-Ethyl-3-thiocyanatocrotonaldehyd 1-amino-1-propylthiobut-1-en-3-one 2-<1-Ethoxycarbonyl-ethyliden>-3-methyl-thiazolid-4-on (s-cis-TRANS) (4aS,8aS)-2-(butylsulfanylmethylidene)-5,5,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-one